This site is intended for healthcare professionals
Drug news

Horizon files sNDA to extend the indication of Ravicti to include infants younger than two months of age living with urea cycle disorders.

Read time: 1 mins
Last updated:1st Mar 2018
Published:1st Mar 2018
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest